Literature DB >> 26008813

Neuromuscular issues in systemic disease.

Wolfgang Grisold1, Anna Grisold.   

Abstract

The neuromuscular system can be involved in several systemic conditions. Clinical manifestations can appear at onset or throughout the course of the disease process. New investigational methods, including imaging of peripheral nerves, new laboratory tests, and antibodies, are available. In addition to symptomatic therapies, specific treatment options, such as for familial amyloid neuropathy and Fabry's disease, are becoming increasingly available. Pathomechanisms vary depending on the underlying disease process. In addition to metabolic, hormonal, immune, and antibody-mediated mechanisms, in some generalized diseases, genetic causes need to be considered. This review focuses on different aspects of the peripheral nervous system including the nerve roots, plexuses, mononeuropathies and generalized neuropathies, neuromuscular junction disorders, muscle, and autonomic nervous system.

Entities:  

Mesh:

Year:  2015        PMID: 26008813     DOI: 10.1007/s11910-015-0565-x

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   6.030


  118 in total

1.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.

Authors:  G Lauria; S T Hsieh; O Johansson; W R Kennedy; J M Leger; S I Mellgren; M Nolano; I S J Merkies; M Polydefkis; A G Smith; C Sommer; J Valls-Solé
Journal:  Eur J Neurol       Date:  2010-07       Impact factor: 6.089

2.  Lyme myositis.

Authors:  Aaron R Holmgren; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2006-08

3.  Small nerve fiber involvement in CMT1A.

Authors:  Maria Nolano; Fiore Manganelli; Vincenzo Provitera; Chiara Pisciotta; Annamaria Stancanelli; Giuseppe Caporaso; Rosa Iodice; Michael E Shy; Lucio Santoro
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

4.  Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy.

Authors:  Jean-Marc Léger; Karine Viala; Guillaume Nicolas; Alain Créange; Jean-Michel Vallat; Jean Pouget; Pierre Clavelou; Christophe Vial; Andreas Steck; Lucile Musset; Benoit Marin
Journal:  Neurology       Date:  2013-05-10       Impact factor: 9.910

Review 5.  Treatment for paraneoplastic neuropathies.

Authors:  Bruno Giometto; Roberta Vitaliani; Elisabeth Lindeck-Pozza; Wolfgang Grisold; Christian Vedeler
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 6.  Paraproteinemic neuropathies.

Authors:  Michelle L Mauermann
Journal:  Continuum (Minneap Minn)       Date:  2014-10

Review 7.  Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.

Authors:  Michael Mahler; Frederick W Miller; Marvin J Fritzler
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

Review 8.  Lyme neuroborreliosis.

Authors:  Klaus Hansen; Clarissa Crone; Wolfgang Kristoferitsch
Journal:  Handb Clin Neurol       Date:  2013

Review 9.  Evaluation and construction of diagnostic criteria for inclusion body myositis.

Authors:  Thomas E Lloyd; Andrew L Mammen; Anthony A Amato; Michael D Weiss; Merrilee Needham; Steven A Greenberg
Journal:  Neurology       Date:  2014-06-27       Impact factor: 9.910

10.  Carpal tunnel syndrome and peripheral polyneuropathy in patients with end stage kidney disease.

Authors:  Hee-Kyu Kwon; Sung-Bom Pyun; Won Yong Cho; Chang Su Boo
Journal:  J Korean Med Sci       Date:  2011-09-01       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.